Quoting the early experiences with hydrocortisone acetate it was found that an optimal response was obtained when a joint was injected, which could be reduced by over-or under-dosage. Thus, an optimal dose was established for each joint. Some io% of lesions failed to respond to the local injection although similar lesions had responded. Some cases experienced marked post-injection pain, some arthritic joints became worse after injection, and a very few responded allergically to the injection. Of all these drawbacks the most important were the temporary worsening of the arthritis, the marked post-injection pain, and the failure to respond in IO per cent. of cases. The duration of improvement in joint symptoms and signs after injection proved a useful measure by which to compare other injections, particularly when there was a recurrence within a short period of time. These are the features which can be used to assess a new preparation for local injection therapy.
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The success of hydrocortisone acetate led to the investigation of other esters and homologues of hydrocortisone. The esters tested included the benzoate, caprylate and the tertiary butyl acetate.
The two former esters were less effective than the tertiary butyl acetate, which was as effective in some hands as the acetate. Pain at the time of injection, and a io% failure rate, however, were drawbacks. Norcross (i958) showed that the bigger the injected dose, the longer the response, thus conflicting with the theory of an optimal dose for each joint.
The homologues of hydrocortisone acetate tested included the 9-alpha-chloro-hydrocortisone, by both authors were given multiple injections of large doses of corticosteroid. We have seen one case where the joint affected had never been injected, but the patient had been for years on oral steroids. The two common factors in these cases are corticosteroid therapy, either oral or local, and continued weight-bearing. The incidence of this complication is very small, and estimated as 0.7% of all injected joints by Hollander, Brown, Jessar, Udell, Smuhler and Bowie (I96I). The radiological appearance is a destructive arthritis, with marked bone absorption and osteoporosis. Clinically, the joint is unstable, but relatively painless, like a Charcot's arthropathy. The incidence can possibly be reduced by avoiding multiple large injections, and ensuring adequate rest.
The next corticosteroid to be used in local injection therapy was dexamethasone. This was available as the phosphate, and as the tertiary butyl acetate. The phosphate had a short duration action which was rapid in onset, features which Christie (I959) had noted with the phosphate of prednisolone. The tertiary butyl acetate had a long action and was very effective, but Thompson (I96I) found that systemic absorption sufficient to enliven a peptic ulcer occurred.
Triamcinolone was the next newcomer. This corticosteroid was presented as the acetonide and the diacetate. These compounds had a high anti-inflammatory potency (Sperling, I960) , but when compared with prednisolone by Holden and Kendall (I96I) , the latter was found to be superior.
Methyl prednisolone is the latest newcomer to the scene. This corticosteroid was presented as the acetate for local injection. The results show that this corticosteroid is very effective in lesions which have not responded to another steroid. The 
